MONTREAL, Nov. 4 /CNW Telbec/ - Haemacure Corporation (TSX:HAE) announced
today that Joseph Galli, Chairman and Chief Executive Officer of Haemacure,
will present at the Rodman and Renshaw Annual Global Investor Conference being
held November 10-12 in New York. Mr. Galli will present a corporate progress
report, including an update on the Company's lead product candidate,
Hemaseel(R)HMN (fibrin sealant). The Haemacure presentation is scheduled to
begin at 3:15 p.m. local time on Monday, November 10th.
